ExodusPoint Capital Management’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-59,491
| Closed | -$211K | – | 1361 |
|
|
2025
Q1 | $211K | Sell |
59,491
-46,746
| -44% | -$166K | ﹤0.01% | 1228 |
|
|
2024
Q4 | $402K | Buy |
+106,237
| New | +$402K | ﹤0.01% | 1101 |
|
|
2024
Q1 | – | Sell |
-72,824
| Closed | -$1.07M | – | 1335 |
|
|
2023
Q4 | $1.07M | Sell |
72,824
-501,799
| -87% | -$7.39M | 0.01% | 735 |
|
|
2023
Q3 | $10.5M | Buy |
574,623
+61,532
| +12% | +$1.13M | 0.1% | 187 |
|
|
2023
Q2 | $11.1M | Buy |
513,091
+119,187
| +30% | +$2.57M | 0.09% | 197 |
|
|
2023
Q1 | $11.6M | Buy |
393,904
+189,967
| +93% | +$5.57M | 0.1% | 187 |
|
|
2022
Q4 | $7.54M | Buy |
203,937
+141,718
| +228% | +$5.24M | 0.11% | 227 |
|
|
2022
Q3 | $1.75M | Buy |
62,219
+46,206
| +289% | +$1.3M | 0.02% | 825 |
|
|
2022
Q2 | $308K | Buy |
+16,013
| New | +$308K | ﹤0.01% | 1469 |
|